Ultrasonic measurement of bladder weight as a possible predictor of acute urinary retention in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

Ultrasound in Medicine and Biology

Volumn 28, Issue 8, 2002, Pages 985-990

  Miyashita, Hiroaki ^a   Kojima, Munekado ^a   Miki, Tsuneharu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Benign prostatic hyperplasia; Bladder ultrasound; Retention

Indexed keywords

DISEASES; PATIENT MONITORING; RISKS;

BLADDER WEIGHT;

ULTRASONIC MEASUREMENT;

ADULT; AGED; ARTICLE; BLADDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN WEIGHT; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; SYMPTOM; TRANSABDOMINAL ULTRASONOGRAPHY; TRANSRECTAL ULTRASONOGRAPHY; ULTRASOUND; URINARY TRACT; URINE RETENTION; URODYNAMICS;

AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROSTATIC HYPERPLASIA; ROC CURVE; URINARY BLADDER; URINARY RETENTION;

EID: 0036706618     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-5629(02)00545-8     Document Type: Article

References (26)

1. Anderson J.B., Roehrborn C.G., Schalken J.A., Emberton M. The progression of benign prostatic hyperplasia. Examining the evidence and determining the risk. Eur Urol. 39:2001;390-399.
2. Barry M.J., Fowler F.J. Jr, Bin L., Pitis J.C. III, Harris C.J., Mulley A.G. Jr. The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists. J Urol. 157:1997;10-15.
3. Choong S., Emberton M. Acute urinary retention. Br J Urol Int. 85:2000;186-201.
4. Christensen M.M., Bruskewitz R.C. Clinical manifestations of benign prostatic hyperplasia and indications for therapeutic intervention. Urol Clin North Am. 17:1991;509-516.
5. Din K.E., de Wildt M.J., Rosier P.F., Wijkstra H., Debruyne F.M., de la Rosette J.J. The correlation between urodynamic and cystoscopic findings in elderly men with voiding complaints. J Urol. 155:1996;1018-1022.
6. Girman C.J., Epstein R.S., Jacobsen S.J., et al. Natural history of prostatism. Impact of urinary symptoms on quality of life in 2115 randomly selected community men. Urology. 44:1994;825-831.
7. Guzman H.J., Arroyo C.J., Gabilondo F. Comparative study between bladder weight by ultrasound IPSS and urodynamics for infravesical obstruction. J Urol. 163:2000;48.
8. Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:1982;29-36.
9. The evaluation and treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction. Denis L., Griffiths K., Khoury S., et al. Proceedings of the 4th International Consultation on Benign Prostatic Hyperplasia (BPH). Health Publication. 1997;669-684.
10. Jacobsen S.J., Jacobson D.J., Girman C.J., et al. Natural history of prostatism. Risk factors for acute urinary retention. J Urol. 158:1997;481-487.
11. Kaplan S.A., Te A.E., Presler L.B., Olsson C.A. Transition zone index as a method of assessing benign prostatic hyperplasia. Correlation with symptoms, urine flow and detrusor pressure. J Urol. 154:1995;1764-1769.
12. Kojima M., Inui E., Ochiai A., Naya Y., Ukimura O., Watanabe H. Ultrasonic estimation of bladder weight as a measure of bladder hypertrophy in men with infravesical obstruction A preliminary report. Urology. 47:1996;942-947.
13. Kojima M., Inui E., Ochiai A., et al. Reversible change of bladder hypertrophy due to benign prostatic hyperplasia after surgical relief of obstruction. J Urol. 158:1997;89-93.
14. Kojima M., Inui E., Ochiai A., Naya Y., Ukimura O., Watanabe H. Noninvasive quantitative estimation of infravesical obstruction using ultrasonic measurement of bladder weight. J Urol. 157:1997;476-479.
15. Kojima M., Naya Y., Inoue W., et al. The American Urological Association symptom index for benign prostatic hyperplasia as a function of age, volume and ultrasonic appearance of the prostate. J Urol. 157:1997;2160-2165.
16. Kumar V., Marr C., Bhuvangiri A., Irwin P. A prospective study of conservatively managed acute urinary retention. Prostatic size matters. Br J Urol Int. 86:2000;816-819.
17. Kurita Y., Masuda H., Terada H., Suzuki K., Fujita K. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia. Urology. 51:1998;595-600.
18. Manieri C., Carter S.St.C., Romano G., Trucchi A., Valenti M., Tubaro A. The diagnosis of bladder outlet obstruction in men by ultrasound measurement of bladder wall thickness. J Urol. 159:1998;761-765.
19. Marberger M. Long-term effects of finasteride in patients with benign prostatic hyperplasia. A double-blind, placebo-controlled, multicenter study. Urology. 51:1998;677-686.
20. Marberger M.J., Andersen J.T., Nickel J.C., et al. Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Eur Urol. 38:2000;563-568.
21. McNeal J. Pathology of benign prostatic enlargement. Urol Clin North Am. 17:1978;477-486.
22. Naya Y., Kojima M., Honjyo H., Ochiai A., Ukimura O., Watanabe H. Intraobserver and interobserver variance in the measurement of ultrasound-estimated bladder weight. Ultrasound Med Biol. 24:1998;771-773.
23. Powell P.H., Smith P.J., Feneley R.C. The identification of patients at risk from acute retention. Br J Urol. 52:1980;520-522.
24. Resnick N.M., Yalla S.V. Detrusor hyperactivity with impaired contractile function. JAMA. 257:1987;3076-3081.
25. Roehrborn C.G., Bruskewitz R., Nickel G.C., et al. Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Eur Urol. 37:2000;528-536.
26. Roehrborn C.G., McConnell J.D., Lieber M., et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. Urology. 53:1999;473-480.